PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,080.00
-80.00 (-2.53%)
Last updated: Jun 2, 2026, 3:00 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 67.49 billion as of June 3, 2026. Its market cap has decreased by -7.09% in one year.
Market Cap
67.49B
Enterprise Value
72.84B
Revenue
171.66B
Ranking
n/a
PE Ratio
573.17
Stock Price
3,080.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 67.49B, an increase of 519.64%. That is a compound annual growth rate of 6.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 67.49B | -25.87% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 63.74T |
| Celltrion | 40.43T |
| ALTEOGEN | 19.58T |
| Samsung Epis Holdings | 12.04T |
| Enzychem Lifesciences | 76.86B |
| Kukje Pharma | 73.31B |
| Oncocross | 71.59B |
| BIT Computer | 70.43B |